Showing results (1061-1070 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|January 30, 2020
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple SclerosisFinn Sellebjerg, Morten Blinkenberg, Per Soelberg SorensenCNS Drugs|January 30, 2020
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development ProgramTeodora Doherty, Ewa Wajs, Rama Melkote, et al.CNS Drugs|October 28, 2020
Levetiracetam versus Phenytoin for the Pharmacotherapy of Benzodiazepine-Refractory Status Epilepticus: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsTao Xue, Luxin Wei, Xiaotian Shen, et al.CNS Drugs|October 16, 2020
The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular DiseasesLauren M Behlke, Eric J Lenze, Robert M CarneyCNS Drugs|October 3, 2020
Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover StudyKim S J Lao, Jiaxi Zhao, Joseph Edgar Blais, et al.CNS Drugs|April 5, 2020
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for SchizophreniaNicholas Keks, Judith Hope, Darren Schwartz, et al.CNS Drugs|April 5, 2020
Potential of Glial Cell Modulators in the Management of Substance Use DisordersJermaine D JonesCNS Drugs|July 9, 2021
Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and EffectivelySamuel R Chamberlain, David S BaldwinCNS Drugs|July 2, 2022
The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical TrialsErin G Doty, Paula M Hauck, John H Krege, et al.CNS Drugs|May 5, 2022
Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological StrategiesKatharine N Gurba, Rida Chaudhry, Simon HaroutounianPageof 211